Dr Russell E Hillsley, MD | |
3407 Wilkens Ave, Suite 300, Baltimore, MD 21229-5072 | |
(410) 644-5111 | |
(410) 644-2715 |
Full Name | Dr Russell E Hillsley |
---|---|
Gender | Male |
Speciality | Cardiac Electrophysiology |
Experience | 36 Years |
Location | 3407 Wilkens Ave, Baltimore, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649273954 | NPI | - | NPPES |
206638600 | Medicaid | MD |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St. Agnes Healthcare, Inc. | 9830092733 | 237 |
News Archive
A novel compound similar in structure to the psychedelic drug ibogaine, but lacking its toxic and hallucinogenic effects, has been found to rapidly reverse the effects of stress in mice.
A team of scientists from the United States has found that oral salivary samples are less sensitive than nasal-oropharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA
In a surprising finding, a collaborative national clinical trials group (RTOG) including Dartmouth-Hitchcock's Alan Hartford, MD, PhD, discovered that radiation therapy in addition to chemotherapy was even more effective at preventing recurrence of ductal carcinoma in situ (DCIS) than previously thought.
Mirati Therapeutics, Inc., an oncology company focusing on genetic and epigenetic drivers of cancer, today announced it will present data on its tyrosine kinase inhibitor, MGCD516, at the ESMO 2015 European Cancer Congress being held in Vienna, Austria from September 25-29, 2015.
› Verified 4 days ago
Entity Name | St. Agnes Healthcare, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144250176 PECOS PAC ID: 9830092733 Enrollment ID: O20040128001146 |
News Archive
A novel compound similar in structure to the psychedelic drug ibogaine, but lacking its toxic and hallucinogenic effects, has been found to rapidly reverse the effects of stress in mice.
A team of scientists from the United States has found that oral salivary samples are less sensitive than nasal-oropharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA
In a surprising finding, a collaborative national clinical trials group (RTOG) including Dartmouth-Hitchcock's Alan Hartford, MD, PhD, discovered that radiation therapy in addition to chemotherapy was even more effective at preventing recurrence of ductal carcinoma in situ (DCIS) than previously thought.
Mirati Therapeutics, Inc., an oncology company focusing on genetic and epigenetic drivers of cancer, today announced it will present data on its tyrosine kinase inhibitor, MGCD516, at the ESMO 2015 European Cancer Congress being held in Vienna, Austria from September 25-29, 2015.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Russell E Hillsley, MD 3407 Wilkens Ave, Suite 300, Baltimore, MD 21229-5072 Ph: (410) 644-5111 | Dr Russell E Hillsley, MD 3407 Wilkens Ave, Suite 300, Baltimore, MD 21229-5072 Ph: (410) 644-5111 |
News Archive
A novel compound similar in structure to the psychedelic drug ibogaine, but lacking its toxic and hallucinogenic effects, has been found to rapidly reverse the effects of stress in mice.
A team of scientists from the United States has found that oral salivary samples are less sensitive than nasal-oropharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA
In a surprising finding, a collaborative national clinical trials group (RTOG) including Dartmouth-Hitchcock's Alan Hartford, MD, PhD, discovered that radiation therapy in addition to chemotherapy was even more effective at preventing recurrence of ductal carcinoma in situ (DCIS) than previously thought.
Mirati Therapeutics, Inc., an oncology company focusing on genetic and epigenetic drivers of cancer, today announced it will present data on its tyrosine kinase inhibitor, MGCD516, at the ESMO 2015 European Cancer Congress being held in Vienna, Austria from September 25-29, 2015.
› Verified 4 days ago
Dr. Leonard Anang Sowah, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-706-4619 Fax: 410-706-2062 | |
Dr. Bhavandeep Singh Bajaj, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3345 Wilkens Avenue, Suite L10, Baltimore, MD 21229 Phone: 410-644-4444 Fax: 410-644-4484 | |
Dr. Yonas Sisay, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 822 Guilford Ave, #100, Baltimore, MD 21202 Phone: 410-385-9672 | |
Dr. Stephen John Witanowski, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 2700 Quarry Lake Dr, Suite 280, Baltimore, MD 21209 Phone: 410-469-5544 Fax: 410-585-2867 | |
Dr. Susrutha Kotwal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Mfl Bldg, West Tower, 6th Floor, Baltimore, MD 21224 Phone: 410-550-5018 | |
Dr. Mitesh G Trambadia, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 6701 N Charles St Ste 5218, Baltimore, MD 21204 Phone: 443-849-3786 | |
Ronak K Patel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 E University Pkwy, Baltimore, MD 21218 Phone: 410-554-2000 |